Predictive Oncology (POAI) Stock Forecast & Price Target

$0.92

+0.02 (+2.23%)

(As of 09/17/2024 ET)

Predictive Oncology - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy
Based on 1 Analyst Ratings

Based on 1 Wall Street analysts who have issued ratings for Predictive Oncology in the last 12 months, the stock has a consensus rating of "Buy." Out of the 1 analysts, 1 has given a buy rating for POAI.

Consensus Price Target

$3.00
227.69% Upside

High Forecast	$3.00
Average Forecast	$3.00
Low Forecast	$3.00

According to the 1 analysts' twelve-month price targets for Predictive Oncology, the average price target is $3.00. The highest price target for POAI is $3.00, while the lowest price target for POAI is $3.00. The average price target represents a forecasted upside of 227.69% from the current price of $0.92.

Type	Current Forecast 9/18/23 to 9/17/24	1 Month Ago 8/19/23 to 8/18/24	3 Months Ago 6/20/23 to 6/19/24	1 Year Ago 9/18/22 to 9/18/23
Consensus Rating	Buy	N/A	N/A	N/A
Strong Buy	0 Strong Buy rating(s)	N/A	N/A	N/A
Buy	1 Buy rating(s)	N/A	N/A	N/A
Hold	0 Hold rating(s)	N/A	N/A	N/A
Sell	0 Sell rating(s)	N/A	N/A	N/A
Consensus Price Target	$3.00	N/A	N/A	N/A
Forecasted Upside	227.69% Upside	N/A	N/A	N/A

[Urgent] Starlink Set For The Largest IPO In History? (Ad)

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.

Click here now for the urgent details on this hidden play.

POAI Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

POAI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Predictive Oncology Stock vs. The Competition

Type	Predictive Oncology	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.77	2.50
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	227.69% Upside	1,015.17% Upside	7.92% Upside
News Sentiment Rating	Neutral News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date	Details
8/19/2024	HC Wainwright 2 of 5 stars	S. Ramakanth Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$3.00	+242.85%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 10:48 PM ET.

POAI Forecast - Frequently Asked Questions

What is Predictive Oncology's forecast for 2024?: According to the research reports of 1 Wall Street equities research analysts, the average twelve-month stock price forecast for Predictive Oncology is $3.00, with a high forecast of $3.00 and a low forecast of $3.00.
Should I buy or sell Predictive Oncology stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Predictive Oncology in the last year. There is currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" POAI shares.
Does Predictive Oncology's stock price have much upside?: According to analysts, Predictive Oncology's stock has a predicted upside of 242.86% based on their 12-month stock forecasts.
What analysts cover Predictive Oncology?: Predictive Oncology has been rated by research analysts at HC Wainwright in the past 90 days.
Do Wall Street analysts like Predictive Oncology more than its competitors?: Analysts like Predictive Oncology more than other "medical" companies. The consensus rating for Predictive Oncology is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how POAI compares to other companies.